210 related articles for article (PubMed ID: 20001169)
21. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
Clark BE; Siracuse MV; Garis RI
Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
[TBL] [Abstract][Full Text] [Related]
22. Use of generic cardiovascular medications by elderly Medicare beneficiaries receiving generalist or cardiologist care.
Federman AD; Halm EA; Siu AL
Med Care; 2007 Feb; 45(2):109-15. PubMed ID: 17224772
[TBL] [Abstract][Full Text] [Related]
23. Dispensing pattern of generic and brand-name drugs in children.
Chen AY; Wu S
Ambul Pediatr; 2008; 8(3):189-94. PubMed ID: 18501866
[TBL] [Abstract][Full Text] [Related]
24. Physician use of brand versus generic drug names in 1993-1994 and 2003-2004.
Kwo EC; Kamat P; Steinman MA
Ann Pharmacother; 2009 Mar; 43(3):459-68. PubMed ID: 19261956
[TBL] [Abstract][Full Text] [Related]
25. Prescription drug costs and the generic dispensing ratio.
Liberman JN; Roebuck MC
J Manag Care Pharm; 2010 Sep; 16(7):502-6. PubMed ID: 20726679
[TBL] [Abstract][Full Text] [Related]
26. Effective strategies for managing pharmacy benefits.
Jacobson D
Healthc Financ Manage; 2001 Mar; 55(3):41-2. PubMed ID: 11258270
[TBL] [Abstract][Full Text] [Related]
27. Costs and utilization associated with pharmaceutical adherence in a diabetic population.
Hepke KL; Martus MT; Share DA
Am J Manag Care; 2004 Feb; 10(2 Pt 2):144-51. PubMed ID: 15005507
[TBL] [Abstract][Full Text] [Related]
28. Plan-sponsor savings and member experience with point-of-service prescription step therapy.
Motheral BR; Henderson R; Cox ER
Am J Manag Care; 2004 Jul; 10(7 Pt 1):457-64. PubMed ID: 15298367
[TBL] [Abstract][Full Text] [Related]
29. Encouraging generic use can yield significant savings.
Zimmerman C
Find Brief; 2012 Nov; 15(8):1-3. PubMed ID: 23213854
[TBL] [Abstract][Full Text] [Related]
30. [The clinical and economic impact of generic drugs in the treatment of epilepsy].
Argumosa A; Herranz JL
Rev Neurol; 2005 Jul 1-15; 41(1):45-9. PubMed ID: 15999330
[TBL] [Abstract][Full Text] [Related]
31. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.
Mullins CD; Rattinger GB; Kuznik A; Koren MJ
Clin Ther; 2008; 30 Pt 2():2204-16. PubMed ID: 19281915
[TBL] [Abstract][Full Text] [Related]
33. Generic drugs in dermatology: part I.
Payette M; Grant-Kels JM
J Am Acad Dermatol; 2012 Mar; 66(3):343.e1-8; quiz 351-2. PubMed ID: 22342021
[TBL] [Abstract][Full Text] [Related]
34. Limited options to manage specialty drug spending.
Tu HT; Samuel DR
Res Brief; 2012 Apr; (22):1-13. PubMed ID: 23155549
[TBL] [Abstract][Full Text] [Related]
35. Generic drug prescriptions following hospital discharge: a prospective study in France.
Chu C; Rudant E; Bonvalet M; Agostini H; Cavalié P; Bonhomme-Faivre L; Frenkiel J; Taillandier J; Boissonnas A; Vittecoq D; Wyplosz B
Eur J Intern Med; 2011 Oct; 22(5):e45-9. PubMed ID: 21925042
[TBL] [Abstract][Full Text] [Related]
36. Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study.
Gagne JJ; Choudhry NK; Kesselheim AS; Polinski JM; Hutchins D; Matlin OS; Brennan TA; Avorn J; Shrank WH
Ann Intern Med; 2014 Sep; 161(6):400-7. PubMed ID: 25222387
[TBL] [Abstract][Full Text] [Related]
37. Loss of response after switching from brand name to generic formulations: three cases and a discussion of key clinical considerations when switching.
Margolese HC; Wolf Y; Desmarais JE; Beauclair L
Int Clin Psychopharmacol; 2010 May; 25(3):180-2. PubMed ID: 20216221
[TBL] [Abstract][Full Text] [Related]
38. Effects of a physician office generic drug sampling system on generic dispensing ratios and drug costs in a large managed care organization.
Scott AB; Culley EJ; O'Donnell J
J Manag Care Pharm; 2007 Jun; 13(5):412-9. PubMed ID: 17605512
[TBL] [Abstract][Full Text] [Related]
39. Generic drugs in dermatology: part II.
Payette M; Grant-Kels JM
J Am Acad Dermatol; 2012 Mar; 66(3):353.e1-15; quiz 367-8. PubMed ID: 22342022
[TBL] [Abstract][Full Text] [Related]
40. Generic switch after ramipril patent expiry is not associated with decreased pharmacy refill compliance: a retrospective study using the DAPI database.
Ude M; Schuessel K; Quinzler R; Leuner K; Müller WE; Schulz M
J Hypertens; 2011 Sep; 29(9):1837-45. PubMed ID: 21738055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
